Skip to main
CTRE
CTRE logo

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 39%
Hold 28%
Sell 6%
Strong Sell 0%

Bulls say

CareTrust REIT is positioned for growth as its year-end 2025 estimated NAV is projected to rise to $24.05 per share, reflecting a solid increase from the prior year's estimate of $21.62 per share. The management's nearly completed portfolio optimization plan, alongside a core portfolio that exhibits signs of recovery, contributes positively to the overall investment outlook. Additionally, the company's strategic acquisitions, such as the $817 million purchase of a UK-based Care REIT, are expected to enhance enterprise value and bolster the growth potential of its healthcare real estate investments.

Bears say

The analysis indicates a negative outlook for CareTrust REIT's stock primarily due to a declining growth forecast and anticipated reductions in cash collections and investment activity, projected to decline by approximately 5% and to around $500 million, respectively. Additionally, the potential impact of California's CA 525 bill on operators' profitability raises concerns over rent pressures, exacerbating risks associated with tenant viability and reimbursement rates amid persistent Medicaid cuts. The company's ongoing stock decline since 2022 further suggests underlying market apprehensions regarding CareTrust REIT’s operational sustainability and overall financial health.

CareTrust REIT (CTRE) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 39% recommend Buy, 28% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 18 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.